Please add your name to this petition.

https://als.quorum.us/campaign/28538/?utm_source=blog AMX0035 is a promising drug from Amylyx, and it has just completed an Open Label Extension (OLE) trial phase. OLE is a common step in drug trials that allows all participants to continue in the drug or opt-in if they were given a placebo. It has delivered statistically significant results, and we are supporting an effort to obtain accelerated FDA approval so that patients like Deb can access AMX0035 as soon as possible.

Please sign this petition and forward to friends or family members.

This is the most exciting news we have received since beginning this journey, and we would desperately love to add this drug to Deb’s regimen of Riluzole and Radicava with hope for more breakthroughs soon.

https://www.massgeneral.org/news/press-release/Investigational-als-drug-prolongs-patient-survival-in-clinical-trial